EMPIRICAL ISSUES IN THE STUDY OF COGNITIVE AGING THROUGH POPULATION-BASED STUDIES
|
|
- Jayson Riley
- 5 years ago
- Views:
Transcription
1 EMPIRICAL ISSUES IN THE STUDY OF COGNITIVE AGING THROUGH POPULATION-BASED STUDIES Silvia Mejía-Arango* and Brian Downer** *El Colegio de la Frontera Norte, Tijuana, Mexico **University of Texas Medical Branch, Galveston, Texas UNIVERSITY OF SOUTHERN CALIFORNIA / LOS ANGELES, CALIFORNIA / SEPTEMBER 20 22, 2017
2 WORK GROUP REBECA WONG (UTMB) RAFAEL SAMPER (UTMB) MARC GARCIA (UTMB) JOSEPH SAENZ (USC) BRIAN DOWNER (UTMB) SILVIA MEJIA (COLEF) INTERNATIONAL CONFERENCE ON AGING IN THE AMERICAS 2
3 OBJECTIVES Present a conceptual framework for the analysis of cognitive aging in population-based studies. Describe the process of operationalization of the concepts into measurable variables. Show the results when applying the conceptual framework and operationalization process in the Mexican Health and Aging Study. Discuss the importance of missing data in the study of cognitive aging in population-based studies. INTERNATIONAL CONFERENCE ON AGING IN THE AMERICAS 3
4 REFERENCES Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C.,... & Snyder, P. J. (2011). The diagnosis of mild cognitive impairment due to Alzheimer s disease: Recommendations from the National Institute on Aging-Alzheimer s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia, 7(3), Crimmins, E. M., Kim, J. K., Langa, K. M., & Weir, D. R. (2011). Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study. Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 66(suppl_1), i162-i171. Liverman, C. T., Yaffe, K., & Blazer, D. G. (Eds.). (2015). Cognitive aging: Progress in understanding and opportunities for action. National Academies Press. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H.,... & Mohs, R. C. (2011). The diagnosis of dementia due to Alzheimer s disease: Recommendations from the National Institute on Aging-Alzheimer s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia, 7(3), Mejía-Arango, S., Wong, R., & Michaels-Obregón, A. (2015). Normative and standardized data for cognitive measures in the Mexican Healt Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer's disease. The Lancet Neurology, 11(11), h and Aging Study. salud pública de méxico, 57, s90-s96. UNIVERSITY OF SOUTHERN CALIFORNIA, LOS ANGELES, CALIFORNIA, SEPTEMBER 20 22,
5 PROGRESSION FROM NORMAL AGING TO DEMENTIA NORMAL AGING MILD COGNITIVE IMPAIRMENT COGNITIVE DECLINE No Functional Impairment Interference with the ability to function independently DEMENTIA TIME (YEARS)
6 CONCEPTUAL FRAMEWORK 6
7 Macro-social Context Institutional and Public Policy Context Environmental Context OPERATIONALIZATION PROCESS (MHAS) Subjects: proxy and direct interview Life-course Conditions Neurodegenerative Disease Cognitive Impairment Proxy Cognitive IQCODE Direct Cognitive Performance Direct Activities of Daily Living domains 1 IADL Current Conditions BRAIN AND NEURAL CHANGES DURING AGING Functional Impairment Normal Cognition CIND DEMENTIA YES YES YES NO YES Genetic factors Normal Brain Changes Normal Function NORMAL NO NO NO NO YES Brain and Cognitive Reserve 7
8 PRILIMINARY RESULTS MHAS (2015) UNIVERSITY OF SOUTHERN CALIFORNIA, LOS ANGELES, CALIFORNIA, SEPTEMBER 20 22,
9 Age Education Gender Locality
10 MISSING DATA FOR COGNITIVE TASKS
11 Age, n (%) MISSING DATA BY AGE FOR DIRECT RESPONDENTS AGED 60 AND OLDER IN 2015 (N=9,630) Verbal Learning Verbal Recall Visuospatial Learning Cognitive Task Visuospatial Recall Visual Scan Orientation Verbal Fluency Numeracy Missing (0.8) 18 (0.8) 105 (4.9) 114 (5.3) 106 (5.0) 12 (0.6) 18 (0.8) 69 (3.2) 155 (7.3) (0.7) 26 (1.0) 151 (5.5) 173 (6.4) 152 (5.6) 13 ( (0.7) 104 (3.8) 232 (8.5) (0.9) 20 (1.0) 161 (7.9) 183 (9.0) 161 (7.9) 11 (0.7) 16 (0.8) 128 (6.3) 270 (13.3) (1.1) 18 (1.3) 139 (10.1) 158 (11.4) 144 (10.4) 10 (1.2) 13 (0.9) 107 (7.7) 220 (15.9) (1.7) 21 (2.5) 135 (16.1) 153 (18.3) 144 (17.2) 10 (1.2) 14 (1.7) 103 (12.3) 217 (25.9) (1.4) 9 (2.6) 79 (22.8) 91 (26.2) 82 (23.6) 2 (0.6) 5 (1.4) 46 (13.3) 114 (32.9) (4.0) 7 (4.0) 60 (34.7) 65 (37.6) 64 (37.0) 5 (2.9) 7 (4.0) 31 (17.9) 83 (48.0) Total 96 (1.0) 119 (1.2) 830 (8.6) 937 (9.7) 853 (8.9) 63 (0.7) 93 (1.0) 588 (6.1) 1291 (13.4)
12
13 SUMMARY MHAS Cognition Work Group is in the process of publishing the conceptual framework Will provide programing codes and variables for cognitive status available to MHAS data users. 68.9% of participants in 2015 classified as cognitively intact 21.9% of participants classified as CIND. 9.2% of participants classified as dementia. Frequency of CIND and dementia increase according to age, lower education, female gender, and rural communities.
14 RECOMMENDATIONS Missing data for cognitive functioning is a concern in the MHAS Imputation of missing data for direct respondents (ongoing) If possible, avoid restricting analyses to only direct respondents who completed all cognitive tasks Include proxies when evaluating cognitive status
Classification of Persons by Dementia Status in the National Health and Aging Trends Study
Classification of Persons by Dementia Status in the National Health and Aging Trends Study Judith D. Kasper, PhD Johns Hopkins University Vicki A. Freedman, PhD University of Michigan Brenda C. Spillman,
More informationThe role of education in the association between race/ethnicity/nativity, cognitive impairment, and dementia among older adults in the United States
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Sociology Department, Faculty Publications Sociology, Department of 2018 The role of education in the association between
More informationNormative and standardized data for cognitive measures in the Mexican Health and Aging Study
Normative and standardized data for cognitive measures in the Mexican Health and Aging Study Silvia Mejía-Arango, PhD, (1) Rebeca Wong, PhD, (2-4), Alejandra Michaels-Obregón, MS, MBA. (2,4) Mejía-Arango
More informationLIFE expectancy at older ages has been increasing, and
Crimmins, E.M., Kim, J.K., Langa, K.M., & Weir, D.R. (2011). Assessment of cognition using surveys and neuropsychological assessment: the health and retirement study and the aging, demographics, and memory
More informationDEPRESSIVE SYMPTOMS IN ADULT CHILD CAREGIVERS OF VERY OLD MEXICAN AMERICANS: A STUDY OF THE HEPESE
DEPRESSIVE SYMPTOMS IN ADULT CHILD CAREGIVERS OF VERY OLD MEXICAN AMERICANS: A STUDY OF THE HEPESE David V. Flores, PhD, LMSW, MPH University of Texas Medical Branch Galveston UNIVERSITY OF SOUTHERN CALIFORNIA
More informationKorean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP)
Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP) Yeonwook Kang, Ph.D. Department of Psychology, Hallym University Department of Neurology, Hallym University Sacred Heart
More informationThe Role of Education in the Relationship Between Age of Migration to the United States and Risk of Cognitive Impairment Among Older Mexican Americans
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Sociology Department, Faculty Publications Sociology, Department of 2018 The Role of Education in the Relationship Between
More informationNeurology for the Non Neurologist
ADC Administrators Meeting Vancouver, BC April 18, 2016 Neurology for the Non Neurologist Steven T. DeKosky, MD, FACP, FAAN Interim Executive Director, McKnight Brain Institute Aerts/Cosper Professor of
More informationComments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues
Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic s? The Debate Continues Ever since new criteria came out for a research diagnosis of prodromal/preclinical
More informationSex Differences in Cognitive Decline in Mild Cognitive Impairment and Alzheimer's Disease
Brigham Young University BYU ScholarsArchive All Theses and Dissertations 2016-07-01 Sex Differences in Cognitive Decline in Mild Cognitive Impairment and Alzheimer's Disease Juliann Thompson Brigham Young
More informationMild Cognitive Impairment
Mild Cognitive Impairment Victor W. Henderson, MD, MS Departments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences Stanford University Director, Stanford Alzheimer s
More informationNEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES.
NEXT-Link DEMENTIA A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA NEXT-Link DEMENTIA is a network of Danish
More informationDepartment of Neurology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
Print ISSN 1738-1495 / On-line ISSN 2384-0757 Dement Neurocogn Disord 2015;14(4):158-162 / http://dx.doi.org/10.12779/dnd.2015.14.4.158 ORIGINAL ARTICLE DND The Clinical Characteristics according to the
More informationJanuary 18 th, 2018 Brixen, Italy
From Subjective Cognitive Decline to Alzheimer s Disease: the predictive role of neuropsychological, personality and cognitive reserve features. A 7-years Follow-Up study. S. Mazzeo *, V. Bessi *, S. Padiglioni
More informationNew diagnostic criteria for Alzheimer s disease and mild cognitive impairment for the practical neurologist
New diagnostic criteria for Alzheimer s disease and mild cognitive impairment for the practical neurologist Andrew E Budson, 1,2 Paul R Solomon 2,3 1 Center for Translational Cognitive Neuroscience, VA
More informationCognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.
Cognitive Screening in Risk Assessment Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University Outline of Talk Definition of Dementia and MCI Incidence and Prevalence
More informationTrajectories of different cognitive domains in community-dwelling older adults
Trajectories of different cognitive domains in community-dwelling older adults Jennifer Tang, Tianyin Liu, Gloria Wong, Mandy Lau, & Terry Lum 32 nd International Conference of Alzheimer s Disease International
More informationWHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014
WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014 1. Introduction This release consists of a single data set from the WHIMS Epidemiology of Cognitive Health Outcomes
More informationCurrently Used Measures of Cognitive Impairment An HBRN Scholar Special Presentation & Discussion
Currently Used Measures of Cognitive Impairment An HBRN Scholar Special Presentation & Discussion Laura M. Vitkus MPH Student, Health Behavior Health Promotion, Class of 2018 University of Arizona, College
More informationDiversity and Dementia
Diversity and Dementia Kala M. Mehta, DSc, MPH January 17, 2012 Overview Background Incidence and Prevalence of Dementia Why are these differences found? What s important for diverse dementia patients
More informationMeasure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care
Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage
More informationService Related Project. Kimberley Keegan
AN EVALUATION OF ADDENBROOKE S COGNITIVE EXAMINATION III (ACE-III) SCORES, NEUROPSYCHOLOGICAL ASSESSMENT SCORES, AND DIAGNOSIS OUTCOME WITHIN A MEMORY SERVICE. Service Related Project Kimberley Keegan
More informationDementia Prepared by: Joanne Leung Psychiatry Resident, University of Toronto
Dementia Prepared by: Joanne Leung Psychiatry Resident, University of Toronto Dementias are acquired neurodegenerative disorders involving a syndrome of cognitive impairment accompanied with social and
More informationQuality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care
Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:
More informationTest Assessment Description Ref. Global Deterioration Rating Scale Dementia severity Rating scale of dementia stages (2) (4) delayed recognition
Table S. Cognitive tests used in the Georgia Centenarian Study. Test Assessment Description Ref. Mini-Mental State Examination Global cognitive performance A brief screening of orientation, memory, executive
More informationClinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly
Hindawi Publishing Corporation Depression Research and Treatment Volume 2011, Article ID 396958, 6 pages doi:10.1155/2011/396958 Clinical Study Depressive Symptom Clusters and Neuropsychological Performance
More informationAdding the AD8 Dementia Screen to the Panel Study of Income Dynamics
Technical Series Paper #19-01 Adding the AD8 Dementia Screen to the Panel Study of Income Dynamics Vicki A. Freedman Brooke Helppie McFall Lindsay Ryan Institute for Social Research, University of Michigan
More informationDeterminants of Activity Levels in African Americans With Mild Cognitive Impairment.
Thomas Jefferson University Jefferson Digital Commons Department of Neurology Faculty Papers Department of Neurology 1-1-2016 Determinants of Activity Levels in African Americans With Mild Cognitive Impairment.
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea Supplemental Methods Participants From
More informationPreventing Cognitive Decline and Dementia A Way Forward
Preventing Cognitive Decline and Dementia A Way Forward Ronald C. Petersen, PhD, MD Mayo Clinic Rochester, MN USA for Committee on Preventing Cognitive Decline National Academies of Science, Engineering
More informationCognitive testing: Purpose, scope, innovation. Claudia Jacova Assistant Professor Division of Neurology
Cognitive testing: Purpose, scope, innovation Claudia Jacova Assistant Professor Division of Neurology Cognition All mental processes involved in acquiring, storing and utilizing information Pretty much
More informationBiomarkers and undiagnosed disease
Biomarkers and undiagnosed disease Soham Al Snih, MD, Ph.D The University of Texas Medical Branch, Galveston, TX May 29, 2015 Mexico City, Mexico Biomarkers Broad subcategory of medical signs Objective
More informationLambros Messinis PhD. Neuropsychology Section, Department of Neurology, University of Patras Medical School
Lambros Messinis PhD Neuropsychology Section, Department of Neurology, University of Patras Medical School Type 2 Diabetes Mellitus is a modern day epidemic Age is a significant predictor of diabetes Males
More informationDESCRIPTION: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months
Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Prevention, Treatment, and Management of Mental Health 2019 COLLECTION
More informationHow can the new diagnostic criteria improve patient selection for DM therapy trials
How can the new diagnostic criteria improve patient selection for DM therapy trials Amsterdam, August 2015 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM)
More informationMeasurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History
Measurement and Classification of Neurocognitive Disability in HIV/AIDS Robert K. Heaton Ph.D University of California San Diego Ancient History Group Means for NP and MMPI Variables N=381 Consecutive
More informationDisclosure Statement
Recommendations on MCI from the Third and Fourth Canadian Consensus Conferences on Diagnosis and Therapy of Dementia/ Quatrieme Conférence Canadienne Consensuelle sur la Démence 2012. Dr. Howard Chertkow
More informationSOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS
SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS Dr Paraskevi Sakka Neurologist - Psychiatrist Athens Association of Alzheimer s Disease and Related Disorders Neurodegenerative
More informationThe ABCs of Dementia Diagnosis
The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What
More informationConcept paper on no need for revision of the guideline on medicinal products for the treatment of Alzheimer's disease and other dementias
15 March 20122 EMA/CHMP/60715/2012 Committee for Medicinal Products for Human Use (CHMP) Concept paper on no need for revision of the guideline on medicinal products for the treatment of Alzheimer's disease
More informationPost Stroke Cognitive Decline
Post Stroke Cognitive Decline Deborah A. Levine, MD, MPH Departments of Medicine & Neurology University of Michigan deblevin@umich.edu Presenter Disclosure Information Deborah A. Levine, MD, MPH Post Stroke
More informationImaging in Dementia:
Imaging in Dementia: Options for Clinical Practice 2017 John A. Bertelson, MD Clinical Chief of Neurology, Seton Brain and Spine Institute Assistant Professor of Medicine, Dell Medical School, UT Austin
More informationNEUROPSYCHOLOGICAL ASSESSMENT
English 3 CANADIAN STUDY OF HEALTH AND AGING - 3 NEUROPSYCHOLOGICAL ASSESSMENT Interview date: / / DD MM YYYY Time started : (24 Hour clock) Page 2 completed by coordinator Pages 3 to 16 completed by psychometrist
More informationChanging diagnostic criteria for AD - Impact on Clinical trials
Changing diagnostic criteria for AD - Impact on Clinical trials London, November 2014 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM) Salpêtrière Hospital
More informationConference Series on. in the PROGRAM
Conference eries on in the PROGRAM I F W I O M C W P U H R, Thursday, september 17, 2015 8:30-9:00 Registration 9:00-10:00 Welcome Luis Miguel Gutiérrez Robledo, National Institute of Geriatrics, Mexico
More informationPiano playing skills in a patient with frontotemporal dementia: A longitudinal case study
International Symposium on Performance Science ISBN 978-94-90306-01-4 The Author 2009, Published by the AEC All rights reserved Piano playing skills in a patient with frontotemporal dementia: A longitudinal
More informationScreening for Cognitive Impairment
Screening for Cognitive Impairment Screening for Cognitive Impairment. Educational Consultant Pearson April 27, 2017 Presentation Title Arial Bold 7 pt 1 Agenda What is Cognitive Impairment? Implications
More informationNeuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments
Neuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments Jason E. Schillerstrom, MD schillerstr@uthscsa.edu Schillerstrom
More informationCognitive Impairment. Don t Forget It. July 10, Genworth Financial, Inc. All rights reserved.
Cognitive Impairment Don t Forget It July 10, 2013 2012 2013 Genworth Financial, Inc. All rights reserved. Goals of Session To review and understand the new definition of mild cognitive impairment (MCI)
More informationOverview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?
Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric
More informationMild Cognitive Impairment in the General Population: Occurrence and progression to Alzheimer s disease
Mild Cognitive Impairment in the General Population: Occurrence and progression to Alzheimer s disease, Marie Curie Fellow- EU Aging Research Center Department of Neurobiology, Care Sciences and Society
More informationDrug Update. Treatments for Cognitive Impairment in the Older Adult. William Solan, M.D. Karen Sanders, Ph.D. Northwest Hospital Seattle
Drug Update Treatments for Cognitive Impairment in the Older Adult William Solan, M.D. Karen Sanders, Ph.D. Northwest Hospital Seattle Current Drug Treatments for Alzheimer s Disease Cholinesterase Inhibitors:
More informationAPPENDIX: Supplementary Materials for Advance Directives And Nursing. Home Stays Associated With Less Aggressive End-Of-Life Care For
Nicholas LH, Bynum JPW, Iwashnya TJ, Weir DR, Langa KM. Advance directives and nursing home stays associated with less aggressive end-of-life care for patients with severe dementia. Health Aff (MIllwood).
More informationAlzheimer's Disease Brain Failure, Stopping the Momentum. Katherine E. Galluzzi, DO, CMD, FACOFP dist.
AOA/ACOFP 113th Annual Convention and Scientific Seminar Las Vegas, Nevada Alzheimer's Disease Brain Failure, Stopping the Momentum Katherine E. Galluzzi, DO, CMD, FACOFP dist. Monday, October 27, 2008
More informationMethods. Preliminary Results
Parkinson s disease (PD) is one of the most common neurodegenerative diseases, afflicting approximately 1% of adults by age 65 (Shulman et al., 2011). Whereas PD typically presents with a variety of motoric
More informationDISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT
Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease
More informationSignificant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy
Paterson, Abdi 1 Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy Ross W Paterson MRCP 1 *, Zeinab Abdi MRCP 1 *, Amanda Haines RMN 1, Jonathan M
More informationNeuropsychological Evaluation of
Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish
More informationImaging of Alzheimer s Disease: State of the Art
July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression
More informationKey Findings. Friday Harbor Psychometrics Workshop Aug 22 27, Canadian Study of Health and Aging
Key Findings http://www.csha.ca/ Prevalence of Dementia Canada 1991-92 400 Rate per 1,000 350 300 250 200 150 100 50 0 65-74 75-84 85 + Women Men Total Source: Can Med Assoc J 1994;150:899-913 Estimated
More informationAssessment of People with Early Dementia and their Families
Assessment of People with Early Dementia and their Families Claudia K Y Lai, RN, PhD Professor, School of Nursing The Hong Kong Polytechnic University Advanced Management of People with Early Dementia
More information10/19/2017. Cognitive changes of normal aging What is normal, what is not? Dementia, Alzheimer s what s the difference?
Cognitive changes of normal aging What is normal, what is not? Dementia, Alzheimer s what s the difference? Mild Cognitive Impairment and Pre Alzheimer s disease OK, so what can I do? Cognitive Aging:
More informationMARY C MCENIRY Lecturer in statistics, Department of Statistics, University of Wisconsin-Madison.
MARY C MCENIRY CONTACT INFORMATION 4412 Sewell Social Sciences Building University of Wisconsin Madison, Wisconsin 53706 (608) 262-5066 (phone) (608) 262-8400 (fax) mmceniry@ssc.wisc.edu RESEARCH INTERESTS
More informationLillian Hoyle Parent, M.A., OTR, FAOTA
The Open Journal of Occupational Therapy OJOT Sponsor Profiles Spring 2015 Lillian Hoyle Parent, M.A., OTR, FAOTA Follow this and additional works at: http://scholarworks.wmich.edu/sponsorprofiles Recommended
More informationMild cognitive impairment (MCI) is conceptualized as
BRIEF METHODOLOGICAL REPORTS The Montreal Cognitive Assessment Basic: A Screening Tool for Mild Cognitive Impairment in Illiterate and Low-Educated Elderly Adults Parunyou Julayanont, MD,* Sookjaroen Tangwongchai,
More informationIn primary care settings, when patients complain of memory
Ian M. Deutchki, MD University of Rochester Medical Center, NY Ian_Deutchki@URMC. Rochester.edu The author reported no potential conflict of interest relevant to this article. What s causing my older patient
More informationA semantic verbal fluency test for English- and Spanish-speaking older Mexican-Americans
Archives of Clinical Neuropsychology 20 (2005) 199 208 A semantic verbal fluency test for English- and Spanish-speaking older Mexican-Americans Hector M. González a,, Dan Mungas b, Mary N. Haan a a University
More informationHOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE?
EAMA CORE CURRICULUM HOW TO PREVENT COGNITIVE DECLINE.AT MCI STAGE? Sofia Duque Orthogeriatric Unit São Francisco Xavier Hospital Occidental Lisbon Hospital Center University Geriatric Unit, Faculty of
More informationCSF Aβ1-42 predicts cognitive impairment in de novo PD patients
CSF Aβ1-42 predicts cognitive impairment in de novo PD patients Mark Terrelonge MPH *1, Karen Marder MD MPH 1, Daniel Weintraub MD 2, Roy Alcalay MD MS 1 1 Columbia University Department of Neurology 2
More informationWhy Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills
Why Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills Presented by: Dr. William Mansbach CEO & Founder Mansbach Health Tools, LLC www.thebcat.com Highlights on Prevalence
More informationDEMENTIA AND DIAGNOSIS OF DEMENTIA
dementia Unit No. 1 OVERVIEW OF DEMENTIA AND DIAGNOSIS OF DEMENTIA Dr Nagaendran Kandiah ABSTRACT Dementia is a syndrome characterised by cognitive, b e h a v i o u ra l a n d n e u ro lo g i c a l d e
More information21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist
Today s webinar will answer. 1. What is the RBANS, and how is the updated version different than the original version? 2. What are the neurocognitive areas assessed by the RBANS and what scores are available?
More informationWHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide December 2012
WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide December 2012 1. Introduction Changes in the current update (December 2012): New data sets Post Trial - Form A, Phase 2: Administration
More informationRecognizing Dementia can be Tricky
Dementia Abstract Recognizing Dementia can be Tricky Dementia is characterized by multiple cognitive impairments that cause significant functional decline. Based on this brief definition, the initial expectation
More informationTable e-1. MCI diagnosis criteria used by articles included in AAN MCI guideline. MCI diagnosis criteria used by included articles
Memory complaint Cognitive complaint Memory impairment Cognitively impaired Relatively preserved general cognition Intact ADL No dementia CDR 0.5 Table e-1. MCI diagnosis criteria used by articles included
More informationMary C McEniry. Curriculum Vitae, July 2016
CONTACT INFORMATION 4412 Sewell Social Science Building 1180 Observatory Drive University of Wisconsin Madison, Wisconsin 53706-1393 (608) 262-2182 (phone) mmceniry@ssc.wisc.edu RESEARCH INTERESTS Mary
More informationNational estimates of the prevalence of Alzheimer s disease in the United States
Alzheimer s & Dementia 7 (2011) 61 73 National estimates of the prevalence of Alzheimer s disease in the United States Ron Brookmeyer a, *, Denis A. Evans b,c, Liesi Hebert b, Kenneth M. Langa d,e,f, Steven
More informationAssessment for the Model Predicting of the Cognitive and Language Ability in the Mild Dementia by the Method of Data-Mining Technique
Assessment for the Model Predicting of the Cognitive and Language Ability in the Mild Dementia by the Method of Data-Mining Technique Haewon Byeon Department of Speech Language Pathology & Audiology Nambu
More informationEvaluation of Suspected Dementia
Evaluation of Suspected Dementia B. BRENT SIMMONS, MD, and BRETT HARTMANN, MD, Drexel University College of Medicine, Philadelphia, Pennsylvania DANIEL DEJOSEPH, MD, The Commonwealth Medical College, Scranton,
More informationStatins and Cognition A Focus on Mechanisms
Statins and Cognition A Focus on Mechanisms Note: Deleted copyrighted graphs/tables are described In red text and source references are provided Disclosures: SPARCL Steering Committee and past consultant
More informationTHE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER
THE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER Casey A. Boyd, Jaime Benarroch, Kristin M. Sheffield, Yimei Han, Catherine D. Cooksley, Taylor S. Riall Department of Surgery The University of Texas Medical
More informationMild Cognitive Impairment (MCI)
October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine
More informationCan aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators
Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators ASPREE Randomized, double-blind, placebo-controlled trial for extending healthy
More informationI IADL. See Instrumental activities of daily living (IADL) Idiopathic rapid eye movement sleep behavior disorder (Idiopathic RBD), 136
A Abbreviated mental test (AMT) diagnostic performance, GPCOG, 205 screening instrument, 81 timescales, 214 ACE and revision (ACE-R). See also Addenbrooke s cognitive examination (ACE) clinical diagnosis,
More informationAnalysis of Verbal Fluency Ability in Amnestic and Non-Amnestic Mild Cognitive Impairment
Archives of Clinical Neuropsychology 28 (2013) 721 731 Analysis of Verbal Fluency Ability in Amnestic and Non-Amnestic Mild Cognitive Impairment Alyssa Weakley 1, Maureen Schmitter-Edgecombe 1, *, Jonathan
More informationDevelopment of methodology for conducting clinical trials in frontotemporal lobar degeneration
doi:10.1093/brain/awn234 Brain (2008), 131,2957^2968 Development of methodology for conducting clinical trials in frontotemporal lobar degeneration David S. Knopman, 1 Joel H. Kramer, 2 Bradley F. Boeve,
More informationEngineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos,
Engineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos, Susan Resnik, Sterling Johnson, and Pierre Jedynak Longitudinal
More informationORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS
ORIGINAL ARTICLE Neuroscience DOI: 10.46/jkms.2010.25.7.1071 J Korean Med Sci 2010; 25: 1071-1076 Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring
More informationCognitive Abilities Screening Instrument, Chinese Version 2.0 (CASI C-2.0): Administration and Clinical Application
Continuing Medical Education 180 Cognitive Abilities Screening Instrument, Chinese Version 2.0 (CASI C-2.0): Administration and Clinical Application Ker-Neng Lin 1,2, Pei-Ning Wang 1,3, Hsiu-Chih Liu 1,3,
More informationMild cognitive impairment (MCI) is an intermediate
BRIEF METHODOLOGICAL REPORTS The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment Ziad S. Nasreddine, MD, wz Natalie A. Phillips, PhD, z z Valérie Bédirian, BSc,
More informationThe added value of the IWG-2 diagnostic criteria for Alzheimer s disease
The added value of the IWG-2 diagnostic criteria for Alzheimer s disease Miami, January 2016 Bruno Dubois Head of the Dementia Research Center (IMMA) Director of INSERM Research Unit (ICM) Salpêtrière
More informationAlzheimer s disease affects patients and their caregivers. experience employment complications,
Alzheimer s Disease and Dementia A growing challenge The majority of the elderly population with Alzheimer s disease and related dementia are in fair to poor physical health, and experience limitations
More informationCritical Review: Does reminiscence therapy including life story work improve the quality of life of people with dementia?
Critical Review: Does reminiscence therapy including life story work improve the quality of life of people with dementia? Tiffany Ashford M.Cl.Sc (SLP) Candidate University of Western Ontario: School of
More informationHHS Public Access Author manuscript J Am Geriatr Soc. Author manuscript; available in PMC 2017 January 01.
Effects of Comorbid Depression and Diabetes on Cognitive Decline Among Older Mexican Americans Brian Downer, PhD 1, Benjamin N. Vickers, MS 2, Soham Al Snih, MD, PhD 3, Mukaila Raji, MD, MS 4, and Kyriakos
More informationOctober 22, 2015 Revised December 1, 2016*
NATIONAL HEALTH AND AGING TRENDS STUDY (NHATS) Addendum to Classification of Persons by Dementia Status in the National Health and Aging Trends Study for Rounds 2-5 October 22, 2015 Revised December 1,
More informationComparison of Two Informant Questionnaire Screening Tools for Dementia and Mild Cognitive Impairment: AD8 and IQCODE
Human Development and Family Studies Publications Human Development and Family Studies 2014 Comparison of Two Informant Questionnaire Screening Tools for Dementia and Mild Cognitive Impairment: AD8 and
More informationLuca Rozzini, Anna Ceraso, Marina Zanetti, Silvia Pelizzari, Evita Tomasoni, Vivian Accardo, and Alessandro Padovani
Hindawi Behavioural Neurology Volume 2017, Article ID 3781407, 6 pages https://doi.org/10.1155/2017/3781407 Research Article The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia
More informationNew lexicon and criteria for the diagnosis of Alzheimer's disease
Edith Cowan University Research Online ECU Publications Pre. 2011 2011 New lexicon and criteria for the diagnosis of Alzheimer's disease Hamid Sohrabi Edith Cowan University Michael Weinborn Johanna Badcock
More informationCHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE
CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there
More information